Lexaria Bioscience (LEXX) Research & Development (2017 - 2025)
Historic Research & Development for Lexaria Bioscience (LEXX) over the last 12 years, with Q4 2025 value amounting to $671340.0.
- Lexaria Bioscience's Research & Development fell 6562.91% to $671340.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $7.0 million, marking a year-over-year increase of 8604.79%. This contributed to the annual value of $8.2 million for FY2025, which is 24901.63% up from last year.
- According to the latest figures from Q4 2025, Lexaria Bioscience's Research & Development is $671340.0, which was down 6562.91% from $1.9 million recorded in Q3 2025.
- In the past 5 years, Lexaria Bioscience's Research & Development registered a high of $2.7 million during Q2 2025, and its lowest value of $176398.0 during Q1 2021.
- Over the past 5 years, Lexaria Bioscience's median Research & Development value was $671340.0 (recorded in 2025), while the average stood at $916363.3.
- Its Research & Development has fluctuated over the past 5 years, first surged by 175056.4% in 2021, then plummeted by 6562.91% in 2025.
- Over the past 5 years, Lexaria Bioscience's Research & Development (Quarter) stood at $458709.0 in 2021, then skyrocketed by 80.83% to $829489.0 in 2022, then crashed by 30.74% to $574491.0 in 2023, then surged by 239.99% to $2.0 million in 2024, then plummeted by 65.63% to $671340.0 in 2025.
- Its Research & Development was $671340.0 in Q4 2025, compared to $1.9 million in Q3 2025 and $2.7 million in Q2 2025.